Navigation Links
Kidney Patient Organizations, Kidney Community Come Out in Support of Medicare Secondary Payer (MSP) Extension
Date:12/12/2007

Patient organizations support extending MSP and using savings for improving Medicare program; National Kidney Foundation, Renal Support Network, American Kidney Fund and DaVita Patient Citizens submit letters to Capitol Hill in favor of ESRD provisions

WASHINGTON, Dec. 12 /PRNewswire-USNewswire/ ---Kidney Care Partners -- a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with chronic kidney disease -- and many of its individual member organizations continue to voice their support in the debate over the Medicare Secondary Payer (MSP) provisions to extend the period for end stage renal disease (ESRD) from 30 to 42 months.

"The 12 month extension will generate savings to the Medicare program which can then be used to educate people who have kidney disease and ensure their continued access to high quality care," said Dr. Edward Jones, Chairman of Kidney Care Partners and a practicing nephrologist. "Four leading kidney patient advocacy organizations endorse the MSP extension as being in the best interest of patients, the Medicare program, taxpayers and the renal community. The MSP extension assures access and quality of life sustaining care required by kidney patients."

Kidney failure is the only disease condition where private insurers can deny coverage. Although patients can chose to enroll in Medicare any time after the third month of dialysis, they are required to switch to Medicare after 30 months, even if they would prefer to remain in their private health insurance plan. This may mean that some patients and their families are confronted with higher out-of-pocket costs and less comprehensive health coverage.

While improving quality of care and access for kidney failure patients, the MSP extension would have a negligible cost impact for private employers. The proposal would affect fewer than 10,000 patients nationwide.

In a letter to the Senate Finance Committee, KCP expressed a number of reasons to grant the extension, including: 1) the positive impact on patient care when private payers are incentivized to keep beneficiaries healthy; 2) that having an added year of responsibility for CKD patients would encourage private payers to develop protocols that address patient wellness, prevent hospitalizations and make dialysis safer and more efficient; 3) and that dialysis patients should be afforded the same rights as other patients in choosing how their care is financed.

The Renal Support Network, a patient organization of thousands of people with kidney disease, issued a letter to Senator Debbie Stabenow and the entire Senate Finance committee:

RSN supports the MSP Extension, citing its potential positive benefits to patients. These include extending patient choice and accessing the best quality of care possible, selecting the most comprehensive coverage and having the lowest out-of-pocket costs. It can also allow patients to maintain dependent family coverage and offer some patients access to disease management services that may improve outcomes and reduce overall costs.

In a letter sent to the Senate Finance Committee, the National Kidney Foundation (NKF) writes:

H.R. 3162, the Children's Health and Medicare Protection Act (CHAMP), as passed by the House, contained enhanced benefits for kidney patients. NKF understands the need for an offset in the current Pay-Go environment. Therefore, we reiterate NKF's longstanding decision to support extension of Medicare Secondary Payer, to 42 months, as proposed by the House, provided that the savings are dedicated to improvements to the Medicare ESRD program.

The American Kidney Fund writes in a letter to the Senate Finance Committee:

We understand the difficult budgetary challenges you and your colleagues face and recognize that new spending must be offset by cuts in other areas. We support an additional 12 month extension of Medicare secondary payer (MSP) as a means to generate savings to help offset the costs of other improvements for patients in the ESRD program.

An excerpt of a letter from DaVita Patient Citizens, the largest dialysis patient organization with over 20,000 members - pre-dialysis and dialysis patients as well as their family members - reads:

Besides restricting patients' right to choose to keep their private insurance coverage longer, not extending the MSP period will prevent many of the needed reforms within the ESRD program. One of the most important steps is to provide those individuals at risk of kidney failure with education about the factors associated with kidney disease in the hopes of preventing them from reaching kidney failure. Consistently our members state that they were not aware of the risk factors that cause much of kidney disease--diabetes and hypertension. Prior knowledge could have reduced their risk of kidney failure and possibly dialysis, and the savings that MSP extension would achieve will help fund much-needed education and prevention programs.

"Our community voices strong support for reform in the ESRD program, which includes reforming the current MSP provision," said Jones. "Early identification, prevention and disease management are good for Medicare, taxpayers and patients who depend on quality kidney care."

Kidney Care Partners and its members are dedicated to working together to improve the quality of care for individuals with Chronic Kidney Disease (CKD). For more information, please go to http://ww.kidneycarepartners.com.


'/>"/>
SOURCE Kidney Care Partners
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. Expenses Overshadow Optimism for Kidney Failure Patients
3. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
4. Experimental drug shows promise in advanced kidney cancer
5. New Kidney Disease Can Be Fatal
6. Lowering Blood Protein Wont Help Kidney Patients
7. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
8. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
9. Metabolic syndrome heightens risk for development of uric-acid kidney stones
10. Nighttime Home Dialysis a Boon for Kidney Patients
11. New Survey Reveals Kidney Patients Concern About Medicare Policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... ... (PVDF) based sleep diagnostics sensors, announced today it had completed the first phase ... a mix of domestic and rest of world (ROW) authorized dealers specializing in ...
(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a ... CIO Applications magazine has named the company a “Top 25 Cybersecurity Companies 2017.” ... Cloud to help organizations simply and proactively address potential cybersecurity threats before they happen. ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... and medical device sectors, today announced the winners of its 3rd Annual ELITE ... the most influential people in the healthcare industry today. , Out of more ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability of ... Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to ... ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 ...
(Date:5/23/2017)... ... May 23, 2017 , ... The ... professionals, is pleased to announce the organization’s Certified Strength Coach credential has earned ... Strength Coach (CSC) program validates the competency of qualified candidates for jobs in ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
(Date:5/9/2017)... JERUSALEM , May 9, 2017  Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... today that the Canadian Intellectual Property Office has ... for Oral Administration of Exenatide". The patent covers ... analog. GLP-1 is an incretin hormone ...
(Date:5/6/2017)... is Stroke Awareness Month and Omron Healthcare is reminding ... prevent a stroke: monitor and manage your blood pressure. ... undetected and uncontrolled hypertension is a leading risk factor ... personal heart health technology, recently evolved its mission to ... and is advancing a national public education effort to ...
Breaking Medicine Technology: